US 2002/0164342 A1Published application

Recombinant cat allergen, Fel dI, expressed in baculovirus for diagnosis and treatment of cat allergy

OwnerPaul M. Guyre, Joel Goldstein +2inventors

InventorsPaul M. Guyre, Joel Goldstein, Zining Wu, Amanda Wanwen Sun

Life of this patent

Estimating the term…

Recombinant Fel dI cat allergens expressed in baculovirus for diagnosis and treatment of allergy to cats in humans are provided.

Dependent claims

A composition comprising a baculovirus expressed recombinant Fel dI.

Dependencies are inferred from the claim text.

G01N 33/6893
Involving proteins, peptides or amino acids: related to diseases not provided for elsewhere
A61K 39/35
Medicinal preparations containing antigens or antibodies: allergens
A61P 37/08
Drugs for immunological or allergic disorders: antiallergic agents
C07K 16/283
Against the immunoglobulin superfamily: against Fc-receptors, e.g. CD16, CD32, CD64

From the US filing history. Foreign family members aren’t listed.

Loading patent…